{"id":"W2058272907","doi":"10.1023/b:drug.0000006179.20974.af","title":"Gemcitabine and Cisplatin for Patients with Metastatic or Recurrent Esophageal Carcinoma: A Southwest Oncology Group Study","year":2003,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"ca_institutions":"York University","funders":"National Cancer Institute","keywords":"Gemcitabine; Medicine; Cisplatin; Internal medicine; Regimen; Neutropenia; Chemotherapy; Oncology; Esophageal cancer; Toxicity; Phases of clinical research; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00236343,0.0009236042,0.002327264,0.0005022197,0.0008205176,0.00120319,0.0008303575,0.001579699,0.001804358],"category_scores_gemma":[0.002457676,0.000732703,0.002412664,0.001260762,0.0009360624,0.001569252,0.0005911032,0.002109756,0.0003030292],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001552498,"about_ca_system_score_gemma":0.001906881,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003336428,"about_ca_topic_score_gemma":0.005238822,"domain_scores_codex":[0.9986995,0.0007117697,0.0000991107,0.0001855733,0.0001382015,0.0001658078],"domain_scores_gemma":[0.9981788,0.0004672446,0.0004001257,0.0002005531,0.0001008268,0.0006524448],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4487773,0.01524371,0.4903893,0.0005354853,0.006326547,0.0007152102,0.0005323165,0.001439058,0.005810854,0.0002094454,0.001215347,0.02880533],"study_design_scores_gemma":[0.1059776,0.1504253,0.7286722,0.00009791487,0.007761891,0.0009009259,0.0005100932,0.001252368,0.001230185,0.000260609,0.002836908,0.00007393159],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997812,0.001342068,0.00004279209,0.0001253825,0.00002147222,0.00009694468,0.0002005959,0.000003539889,0.0003550849],"genre_scores_gemma":[0.9972422,0.001261744,0.0001157271,0.0003152282,0.00009790724,0.00009365157,0.000495473,0.000005038442,0.0003730443],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003336428,"threshold_uncertainty_score":0.01249915,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03715668079495866,"score_gpt":0.3237959246812277,"score_spread":0.286639243886269,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}